Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; BBB; blood-brain barrier; BRCA; breast cancer associated; ER; estrogen receptor; CTC; circulating tumor cell; ctDNA; circulating tumor DNA; DRFI; distant recurrence-free interval; DTC; disseminated tumor cell; EMT; epithelial-to-mesenchymal transition;
مقالات ISI گیرنده عامل فاکتور رشد اپیدرمی انسان 2 (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; Hypersensitivity reactions; Drug allergy; Anaphylaxis; Biological agents; Monoclonal antibodies; Tryptase; Epinephrine; Skin testing; Rapid desensitization; AS; Ankylosing spondylitis; ASA; Acetylsalicylic acid; BAT; Basophil activation test; CD; Crohn's
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; Breast cancer; Biomarker; Metabolites; Metabolomics; Micrometastases; Nuclear magnetic resonance spectroscopy; AUC; area under the curve; CERM; Center of Magnetic Resonance; CPMG; Carr-Purcell-Meiboom-Gill; ER; oestrogen receptor; GC; gas chromatogr
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; %ID/g; percent injected dose per gram; 125I-FIAU; 125I-labeled fialuridine; 18F-FDG; 18F-labeled fluorodeoxyglucose; 18F-FLT; 18F-labeled fluorothymidine; 18F-FMT; 18F-labeled D-fluoromethyl tyrosine; ADC; apparent diffusion coefficient; BLI; bioluminesce
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; Glioblastoma; Treatment; Review; Pharmacology; Targeted therapy; Stem cell; AKT; protein kinase B; BBB; blood-brain barrier; BCNU; carmustin; CCNU; lomustin; c-MET; hepatocyte growth factor receptor; EGF(R); epidermal growth factor (receptor); EGFRvIII; e
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; 17-AAG; 17-(Allylamino)-17-demethoxygeldanamycin; 17-DMAG; 17-Dimethylaminoethylamino-17-demethoxygeldanamycin; AKT; v-akt murine thymoma viral oncogene homolog; APC; antigen presenting cell; ATM; Ataxia telangiectasia mutated; ATR; Ataxia telangiectasia
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; TAAs; Tumor-associated antigens; MUC1; Mucin 1; HER2/neu; Human epidermal growth factor receptor 2; CEA; Carcinoembryonic antigen; HLA; Human leukocyte antigen; TSA; Tumor-specific antigen; TAP; Transporter associated with antigen processing; ER; Endoplas
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; AMDIS; automated mass spectral deconvolution and identification system; ANOVA; analysis of variance; EI; electron ionization; ER; estrogen receptor; FH; fumarate hydratase; GC; gas chromatography; HER2; human epidermal growth factor receptor 2; HIF; hypox
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; Breast cancer; Immune system; Biomarkers; Immunotherapies; Immune checkpoint blockade; Tumor vaccines; ADCC; antibody dependent cellular cytotoxicity; BiTES; bispecific single chain monoclonal antibodies; CAR; T cells engineered to express artificial chim
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; Breast cancer; Spinal metastasis; Survival; Treatment; Tumor board; CT; Computed tomography; Her2; Human epidermal growth factor receptor 2; HR; Hormonal receptor; MRI; Magnetic resonance imaging; SRE; Skeletal-related events; UICC; Union for Internationa
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; AuNPs; gold nanoparticles; AuNSs; gold nanoshells; AuNRs; gold nanorods; CTAB; cetyltrimethylammonium bromide; EPR; enhanced permeability and retention; RES; reticuloendothelial system; PEG; polyethylene glycol; NIR; near-infrared; TEM; transmission elect
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; BSA; bovine serum albumin; E2; 17β-estradiol; ER; estrogen receptor; ERAB; estrogen receptor autoantibodies; ERαAB; estrogen receptor α autoantibodies; ERβAB; estrogen receptor β autoantibodies; ERK; extracellular signal-regulated kinase; GPR30; G pr
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; Breast cancer; Oestrogen receptor; Progesterone receptor; Human epidermal growth factor receptor 2; Biomarker;
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; HER2; human epidermal growth factor receptor 2; HER3; human epidermal growth factor receptor 3; HRG; heregulin; IGF-1R; insulin-like growth factor-1 receptor; IGF-1; insulin-like growth factor-1; pAKT; phosphorylated AKT; dsIgG; dual-specific IgG; Immunog
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; Breast cancer; Prognostication; Molecular subtypes; Elderly; 95%CI; 95 percent confidence interval; BCS; breast conservative surgery; CT; chemotherapy; EGFR; epidermal growth factor receptor; ER; estrogen receptor; ET; endocrine therapy; HER2; human epide
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; lncRNA; long/large noncoding RNA; Xist; X-inactive specific transcript; mESC; mouse embryonic stem cell; Evf2; embryonic ventral forebrain 2; Six3os; sine oculis-related homeobox 3 homolog, opposite strand; Dlx1as; distal-less homeobox 1, antisense; EGO;
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; ABCA1; ATP-binding cassette sub-family A member 1; AD; Alzheimer's disease; apoB48; apolipoprotein B-48; APP; amyloid precursor protein; BCMO1; β-carotene 15,15â²-monooxygenase; BLAOA; bovine α-lactalbumin complexed with oleic acid; CD36; cluster of di
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; TAM; tumor-associated macrophage; HR; hormone receptor; ER; estrogen receptor; PR; progesterone receptor; HER2; human epidermal growth factor receptor 2; VEGF; vascular endothelial growth factor; EGFR; epidermal growth factor receptor; HIF; hypoxia-induci
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; ED; early disease; AD; advanced disease; TERT; telomerase reverse transcriptase; TNF; α-tumor necrosis factor alpha; GRHL3; grainy head-like 3; ASCO; American Society of Clinical Oncology; MS; mass spectrometry; REMARK; Reporting Recommendations for Tumo
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; Epigenetics; Phytochemicals; DNA-methylation; Histone-modification; miRNA; Carcinogenesis; Akt; v-akt murine thymoma viral oncogene homolog 1; AP-1; Activator Protein-1; Bax; BCL2-associated X protein; Bcl2; B-cell CLL/lymphoma 2; Bcl-xL; B-cell lymphoma-
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; AAV; adeno-associated viruses; Ad6; adenovirus serotype 6; ABCB5Â +; ATP-binding cassette sub-family B member 5; ALDH; aldehyde dehydrogenase; AML; acute myeloid leukemia; APCs; antigen presenting cells; B7.1; (CD80) cluster of differentiation 80; BCG; Ba
Breast cancer HER2 analysis by extra-short incubation microfluidics-assisted fluorescence in situ hybridization (ESIMA FISH)
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; Fluorescence in situ hybridization; Microfluidics; Breast cancer; HER2; Human epidermal growth factor receptor 2;
Which type of breast cancers is undetectable on ring-type dedicated breast PET?
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; AUC; area under the curve; CI; confidence interval; DbPET; dedicated breast positron emission tomography; FDG; 18F-fluorodeoxyglucose; FOV; field of view; HER2; human epidermal growth factor receptor 2; MRI; magnetic resonance imaging; PEM; positron emiss
para-Sulfonatocalix[4]arene stabilized gold nanoparticles multilayers interfaced to electrodes through host-guest interaction for sensitive ErbB2 detection
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; Human epidermal growth factor receptor 2; Gold nanoparticles; Supramolecule; Electrode interface; Layer by layer;
A nationwide registry-based cohort study of the MammaPrint genomic risk classifier in invasive breast cancer
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; Breast cancer; Adjuvant chemotherapy; Risk assessment; Cohort study; Genomic test; MammaPrint; HER2; human epidermal growth factor receptor 2; ER; estrogen receptor; PR; progesterone receptor; IHC; immunohistochemistry; ISH; in-situ hybridization; ILC; in
Antitumor activity of BJ-1207, a 6-amino-2,4,5-trimethylpyridin-3-ol derivative, in human lung cancer
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; Aminopyridin-3-ols; Non-small cell lung cancer; NADPH oxidase; Stem cell factor; Transforming growth factor-α; Akt; protein kinase B; CAM; chick chorioallantoic membrane; c-KIT; cellular homolog of the feline sarcoma viral oncogene v-kit; DPPH; 1,1-diphe
Microcalcifications in breast cancer: From pathophysiology to diagnosis and prognosis
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; ALP; alkaline phosphatase; BI-RADS; Breast Imaging Reporting and Data System; BMP2; bone morphogenetic protein 2; BSP; bone sialoprotein; CA1; carbonic anhydrase I; COX2; cyclooxygenase-2; DCIS; ductal carcinoma in situ; EMT; epithelial-mesenchymal transi
Construction of humanized anti-HER2 single-chain variable fragments (husFvs) and achievement of potent tumor suppression with the reconstituted husFv-Fdt-tBid immunoapoptotin
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; HER2; Immunogenicity; Humanized scFv; Immunoapoptotin; Targeted cancer therapy; Apoptosis; HER2; human epidermal growth factor receptor 2; scFv; single-chain variable fragment; husFv; humanized e23sFv; VL; light chain variable region; VH; heavy chain vari
Resistance to EGFR inhibitors in non-small cell lung cancer: Clinical management and future perspectives
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; NNSCLC; non-small cell lung cancer; OS; overall survival; EGFR; epidermal growth factor receptor; TKI; tyrosine kinase inhibitor; ALK; Anaplastic lymphoma kinase; MET; mesenchymal epithelial transition factor; PFS; progression free survival; HER2; human e
CCRK is a novel signalling hub exploitable in cancer immunotherapy
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; 9G8; serine and arginine rich splicing factor 7; AKT; AKT serine/threonine kinase; AR; androgen receptor; ARE; androgen response element; ARG1; arginase 1; ATM; ataxia telangiectasia mutated; ATR; ataxia telangiectasia and rad3-related protein; BMDC; mous
Evaluation of nonlinear optical differences between breast cancer cell lines SK-BR-3 and MCF-7; an in vitro study
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; HER2; Human epidermal growth factor receptor 2; ER; Estrogen receptor; PR; Progesterone receptor; FISH; Fluorescence in situ hybridization, Z-scan; Breast cancer; Diagnosis; Nonlinear refractive index; Z-scan;
ADC-histogram analysis in head and neck squamous cell carcinoma. Associations with different histopathological features including expression of EGFR, VEGF, HIF-1α, Her 2 and p53. A preliminary study
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; ADC; apparent diffusion coefficient; DWI; diffusion-weighted imaging; DCE; dynamic-contrast enhanced MRI; HNSCC; head and neck squamous cell carcinoma; p53; tumor protein 53; Hif 1-alpha; hypoxia-inducible factor 1-alpha; VEGF; vascular endothelial growth
Left Ventricular Dysfunction in Cancer Treatment
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; anthracyclines; cancer treatment; cardiotoxicity; HER2-targeted therapy; LV dysfunction; ACCF; American College of Cardiology Foundation; AHA; American Heart Association; ASCO; American Society of Clinical Oncology; ASE; American Society of Echocardiograp
Downregulation of SCARA5 may contribute to breast cancer via promoter hypermethylation
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; SRs; scavanger receptors; SCARA5; scavenger receptor class A, member 5; G6PD; the glucose-6-phosphate dehydrogenase; cDNA; complementary deoxyribonucleic acid; qRT-PCR; quantitative real-time polymerase chain reaction; MSP-PCR; methylation-specific polyme
An automated epifluorescence microscopy imaging assay for the identification of phospho-AKT level modulators in breast cancer cells
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; Assay development; Automated microscopy; Breast cancer; Calcium channels; Gene silencing; High content analysis; EGF; Epidermal growth factor; EGFR; Epidermal growth factor receptor; EMT; Epithelial mesenchymal transition; HER2; Human epidermal growth fac
HDAC inhibitors as epigenetic regulators for cancer immunotherapy
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; AICD; activation-induced cell death; AML; acute myeloid leukemia; APC; antigen-presenting cells; CAR; coxsackie- and adenovirus receptor; CDKs; cyclin-dependent kinases; CG; cancer germline; DCs; dendritic cells; HAT; histone acetyltransferase; HDAC; hist
Phytoestrogens and mycoestrogens interacting with breast cancer proteins
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; AUC; area under the curve; BRCA1; breast cancer 1; BRCA2; breast cancer 2, CAT, catalase; DHT; dihydrotestosterone; EDCs; endocrine disrupting chemicals; ERBB2; human epidermal growth factor receptor 2; ERBBs; epidermal growth factor receptor family; ER-b
Loss of c-KIT expression in breast cancer correlates with malignant transformation of breast epithelium and is mediated by KIT gene promoter DNA hypermethylation
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; Breast Cancer; c-KIT; Epigenetics; DNA methylation; Immunohistochemistry; ADH; Atypical ductal hyperplasia; BCA; Bicinchoninic acid; CML; Chronic myelogenous leukemia; CK5/6; Cytokeratin 5/6; CK903; Cytokeratin 903; DCIS; Ductal Carcinoma in situ; ER; Est
Modulation of in vitro phagocytic uptake and immunogenicity potential of modified Herceptin®-conjugated PLGA-PEG nanoparticles for drug delivery
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; NPs; nanoparticles; TNF-α; tumor necrosis factor alpha; PEG; polyethylene glycol; PLGA; poly (D L- lactide-co-glycolide); MALDI; matrix assisted laser desorption/ionization; TOF; time-of-flight; TFA; trifluoroacetic acid; DCM; dichloromethane; EDC; 1-eth
Nitrated T helper cell epitopes enhance the immunogenicity of HER2 vaccine and induce anti-tumor immunity
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; Human epidermal growth factor receptor 2; Universal T cell epitope; Anti-tumor immunity; Nitration; CTL; cytotoxic T lymphocyte; E:T; effector:target; HER2; Human epidermal growth factor receptor 2; LDH; lactate dehydrogenase; MHC; Major histocompatibilit
Epigenetics of breast cancer: Biology and clinical implication in the era of precision medicine
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; BC; breast Cancer; ER; estrogen Receptor; PgR,PR; progesteron receptor; HER-2; human epidermal growth factor receptor 2; TNBC; triple negative breast cancer; ncRNA; non coding RNA; CpG(s); cytosine-phosphate-guanine dinucleotide(s); 5-me-C; 5-methyl-cytos
Marine fish oil is more potent than plant-based n-3 polyunsaturated fatty acids in the prevention of mammary tumors
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; n-3 PUFA; Breast cancer; Human epidermal growth factor receptor 2; Mammary tumor development; Fatty acid composition;
HER2-targeted gold nanoparticles potentially overcome resistance to trastuzumab in gastric cancer
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; Gold nanoparticle; Trastuzumab resistance; HER2; Gastric cancer; Autophagy; Tmab; trastuzumab; HER2; human epidermal growth factor receptor 2; AuNP; gold nanoparticle; ECD; extracellular domain; ADCC; antibody-dependent cellular cytotoxicity; PTEN; phosph
ER stress and cancer: The FOXO forkhead transcription factor link
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; Endoplasmic reticulum; ER stress; Cancer; FOXO; Forkhead transcription factors; Unfolded protein response; AKT; Protein Kinase B; AKT1; Protein Kinase B Alpha; AMPK; AMP-activated protein kinase; ASK1; Apoptosis Signal Regulated Kinase 1; ATF4; Activating
YAP promotes breast cancer metastasis by repressing growth differentiation factor-15
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; ALPP; alkaline phosphatase; AREG; amphiregulin; α-SMA; alpha smooth muscle actin; BIRC5; baculoviral inhibitor of apoptosis repeat-containing 5; ChIP; chromatin immunoprecipitation; CTGF; connective tissue growth factor; DDIT4; DNA-damage inducible trans
CNOT2 promotes proliferation and angiogenesis via VEGF signaling in MDA-MB-231 breast cancer cells
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; CNOT2; Breast cancer; Tissue array; CAM; VEGF; CCR4-Not complex; carbon catabolite repressed 4-negative on TATA-less complex; EGFR; epidermal growth factor receptor; HER2; human epidermal growth factor receptor 2; TNBC; triple negative breast cancers; VEG
Ampullary carcinoma-A genetic perspective
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; AVC; ampulla of vater carcinoma; KRAS; Kirsten rat sarcoma viral oncogene homolog; OS; overall survival; RFS; recurrence free survival; HER2; human epidermal growth factor receptor 2; BRAF; B rapidly activated fibrosarcoma; BRCA2; breast cancer 2; TP53; t
Antibody-drug conjugates (ADCs): Potent biopharmaceuticals to target solid and hematological cancers- an overview
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; Antibody-drug conjugates; Monoclonal antibodies; Anticancer; Drug resistance; Solid tumors; Hematological tumors; ADC; Antibody-Drug Conjugate; ALCL; Anaplastic Large Cell Lymphoma; ALL; Acute Lymphoblastic Leukemia; AML; Acute Myeloid Leukemia; BCMA; B C
Liposome-chaperoned cell-free synthesis for the design of proteoliposomes: Implications for therapeutic delivery
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; ABC; accelerated blood clearance; AUC; area under the curve; BACE1; β-site APPcleaving enzyme 1; C8bp; C8-binding protein; Cardiolipin; 1,3-bis[1,2-dioleoyl-sn-glycero-3-phospho]-sn-glycerol; CDH2; N-cadherin; CF; cell-free; CHO; Chinese Hamster Ovary ce
ERK1/2 inhibitors: New weapons to inhibit the RAS-regulated RAF-MEK1/2-ERK1/2 pathway
Keywords: گیرنده عامل فاکتور رشد اپیدرمی انسان 2; Akt; oncogene in the transforming retrovirus, AKT8; AP-1; activator protein 1; ARAF; v-raf murine sarcoma 3611 viral oncogene homologue; ASK1; apoptosis signal-regulating kinase 1; BCL2; B-cell lymphoma 2; BCL-XL; B-cell lymphoma extra large; BRAF; v-raf